![Gönül Veliçelebi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gönül Veliçelebi
Directeur Général chez Camino Pharma LLC
Profil
Gönül Veliçelebi was the founder of CalciMedica, Inc. (founded in 2006), CalciMedica, Inc. (US) (founded in 2006), and Camino Pharma LLC (founded in 2014), where she held the title of President & Chief Executive Officer, and Chief Executive Officer, respectively.
Currently, she is a Director at Orphagen Pharmaceuticals since 2013.
Previously, she held positions as Director-Cell Biology at Sibia Neurosciences, Inc., Vice President-Research at MitoKor, Inc., and Vice President-Research & Drug Discovery at TorreyPines Therapeutics, Inc. (from 2000 to 2006).
She also worked as Vice President-Research & Drug Discovery at TorreyPines Therapeutics, Inc. Additionally, she earned a doctorate degree from Yale University and an undergraduate degree from Randolph College, Inc.
Postes actifs de Gönül Veliçelebi
Sociétés | Poste | Début |
---|---|---|
Orphagen Pharmaceuticals
![]() Orphagen Pharmaceuticals Pharmaceuticals: MajorHealth Technology Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 08/01/2013 |
Camino Pharma LLC
![]() Camino Pharma LLC BiotechnologyHealth Technology Camino Pharma LLC is a start-up company based in the United States that focuses on discovering and developing first-in-class therapies for cancer and CNS disorders. The American company targets signaling proteins based on emerging biological concepts and discovers novel mechanisms for modulating these targets with small molecule drugs. Camino Pharma's leadership team has proven expertise in relevant target biology and extensive experience in drug discovery and development. The private company's goal is to discover and develop novel, first-in-class treatments for the most aggressive forms of cancer and poorly addressed psychiatric disorders, including substance use and major depression. Camino Pharma's innovative technology platform allows for exploiting inadequately served targets that require a highly adaptive and specialized approach to drug discovery. | Directeur Général | 01/09/2014 |
Anciens postes connus de Gönül Veliçelebi
Sociétés | Poste | Fin |
---|---|---|
TorreyPines Therapeutics, Inc. /Old/
![]() TorreyPines Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, formerly Neurogenetics, Inc., was founded in 2000. The company discovers & develops small molecule drugs to treat diseases and disorders of the central nervous system. The company is located in La Jolla, CA | Directeur Technique/Scientifique/R&D | 06/10/2006 |
CALCIMEDICA, INC. | Fondateur | - |
Sibia Neurosciences, Inc. | Corporate Officer/Principal | - |
MitoKor, Inc.
![]() MitoKor, Inc. BiotechnologyHealth Technology MitoKor, Inc. provided discovery and diagnostic development of mitochondrial medicine. It was a biotechnology company focused on the research and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. The company was headquartered in San Diego, CA | Directeur Technique/Scientifique/R&D | - |
TorreyPines Therapeutics, Inc.
![]() TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | Directeur Technique/Scientifique/R&D | - |
Formation de Gönül Veliçelebi
Yale University | Doctorate Degree |
Randolph College, Inc. | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CALCIMEDICA, INC. | Health Technology |
Entreprise privées | 7 |
---|---|
Sibia Neurosciences, Inc. | Health Technology |
MitoKor, Inc.
![]() MitoKor, Inc. BiotechnologyHealth Technology MitoKor, Inc. provided discovery and diagnostic development of mitochondrial medicine. It was a biotechnology company focused on the research and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. The company was headquartered in San Diego, CA | Health Technology |
CalciMedica, Inc. (US)
![]() CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Health Technology |
TorreyPines Therapeutics, Inc. /Old/
![]() TorreyPines Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, formerly Neurogenetics, Inc., was founded in 2000. The company discovers & develops small molecule drugs to treat diseases and disorders of the central nervous system. The company is located in La Jolla, CA | Health Technology |
TorreyPines Therapeutics, Inc.
![]() TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | Health Technology |
Orphagen Pharmaceuticals
![]() Orphagen Pharmaceuticals Pharmaceuticals: MajorHealth Technology Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA. | Health Technology |
Camino Pharma LLC
![]() Camino Pharma LLC BiotechnologyHealth Technology Camino Pharma LLC is a start-up company based in the United States that focuses on discovering and developing first-in-class therapies for cancer and CNS disorders. The American company targets signaling proteins based on emerging biological concepts and discovers novel mechanisms for modulating these targets with small molecule drugs. Camino Pharma's leadership team has proven expertise in relevant target biology and extensive experience in drug discovery and development. The private company's goal is to discover and develop novel, first-in-class treatments for the most aggressive forms of cancer and poorly addressed psychiatric disorders, including substance use and major depression. Camino Pharma's innovative technology platform allows for exploiting inadequately served targets that require a highly adaptive and specialized approach to drug discovery. | Health Technology |